126 papers found
Refreshing results…
Supplementary Material
Flow Cytometry in Cancer Immunotherapy: Applications, Quality Assurance, and Future
Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining
TCR-engineered reference samples (TERS) to control T-Cell assay performance: towards an immuno-control kit
Managing Multi-center Flow Cytometry Data for Immune Monitoring
List of Contributors
Immunoguiding, the Final Frontier in the Immunotherapy of Cancer
Characterization of Odor-Active Compounds in Aromatic Caramel by GC-Olfactometry and GC-Mass Spectrometry
Characterisation of odour active compounds in aromatic caramel using GC-olfactometry and GC-mass spectrometry
Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
Text S1
Software S1
Figure S1
Hierarchical Modeling for Rare Event Detection and Cell Subset Alignment across Flow Cytometry Samples
Phase I study of peptide vaccine targeting indeolamine 2,3 dioxygenase in metastatic lung cancer patients.
Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy
Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase
Proteomic identification of Annexin A4 as a novel renal cell carcinoma associated antigen
AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial
Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes
Missing publications? Read more about our data sources.